Prompt and affordable access to essential medicines is a component of almost all domestic and global public health models. As is now well known, the availability and costs of both brand and generic drugs is a function of traditional patent law incentives. Less known, however, is that generic...

This is an introduction to a new development in the international arena that poses a threat to the ability of countries to tailor patent and regulatory laws to promote access to medicine. Basically, certain international agreements permit foreign companies to sue a country for compensation if...

During the recent COVID-19 pandemic crisis, several high-income countries pursued vaccine nationalism (i.e., my country first approaches for vaccine distribution), leading to an even wider income inequality between rich and poor countries. This significantly challenged the poorer countries'...